Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. 薬物名(臨床試験情報から抽出) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Elosulfase alfa
(D10333)
1件: Elosulfase alfa1件: Elosulfase alfa (D10333) 💬1件: GALNS 💬3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬1件: 19 💬
2Elosulfase Alfa 1 MG/ML Intravenous Solution [VIMIZIM]
(D10333)
1件: Elosulfase alfa1件: Elosulfase alfa (D10333) 💬1件: GALNS 💬3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬1件: 19 💬
3Vimizim® (elosulfase alfa)
(D10333)
1件: Elosulfase alfa1件: Elosulfase alfa (D10333) 💬1件: GALNS 💬3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬1件: 19 💬